NasdaqGS - Delayed Quote • USD
MacroGenics, Inc. (MGNX)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 7:52 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 9 | 10 | 7 |
| Avg. Estimate | -0.64 | -0.64 | -2.58 | -2.01 |
| Low Estimate | -0.77 | -0.76 | -2.98 | -3.6 |
| High Estimate | -0.55 | -0.42 | -2.18 | 0.58 |
| Year Ago EPS | -0.61 | 0.92 | -0.15 | -2.58 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 9 | 10 | 6 |
| Avg. Estimate | 14.92M | 16.53M | 68.3M | 139.82M |
| Low Estimate | 10.29M | 10.38M | 42.47M | 70M |
| High Estimate | 22.7M | 37.7M | 125.7M | 326.22M |
| Year Ago Sales | 24.5M | -- | 58.75M | 68.3M |
| Sales Growth (year/est) | -39.10% | -- | 16.30% | 104.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.45 | -0.52 | -0.1 | -0.15 |
| EPS Actual | -0.61 | 0.92 | 0.28 | -0.75 |
| Difference | -1.06 | 1.44 | 0.38 | -0.6 |
| Surprise % | -235.60% | 276.90% | 380.00% | -400.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.64 | -0.64 | -2.58 | -2.01 |
| 7 Days Ago | -0.64 | -0.62 | -2.52 | -2.01 |
| 30 Days Ago | -0.62 | -0.63 | -2.55 | -1.02 |
| 60 Days Ago | -0.47 | -0.49 | -1.87 | -0.99 |
| 90 Days Ago | -0.47 | -0.49 | -1.87 | -1.25 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | MGNX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -4.90% | -- | -- | 0.40% |
| Next Qtr. | -169.60% | -- | -- | 9.90% |
| Current Year | -1,620.00% | -- | -- | 4.30% |
| Next Year | 22.10% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -283.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | TD Cowen: Hold to Buy | 4/9/2024 |
| Reiterates | JMP Securities: Market Outperform | 4/4/2024 |
| Maintains | Citigroup: Buy to Buy | 3/11/2024 |
| Maintains | JMP Securities: Outperform to Outperform | 3/11/2024 |
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 3/11/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 3/8/2024 |
Related Tickers
PEPG PepGen Inc.
11.72
+2.90%
MRSN Mersana Therapeutics, Inc.
3.2100
+1.90%
ENTA Enanta Pharmaceuticals, Inc.
13.15
-2.16%
STRO Sutro Biopharma, Inc.
3.7200
-1.33%
XNCR Xencor, Inc.
18.37
+0.88%
ACLX Arcellx, Inc.
54.44
+4.69%
CTMX CytomX Therapeutics, Inc.
1.6800
+0.60%
FDMT 4D Molecular Therapeutics, Inc.
24.81
-5.99%
MRUS Merus N.V.
40.82
+0.91%
BCYC Bicycle Therapeutics plc
22.68
+0.49%